Mingyue Jia

Yangguang South Street
Fangshan, 102488, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Panax ginseng extract reduces citrinin production and attenuates nephrotoxicity in Monascus purpureus.

Panax ginseng extract reduces citrinin production and attenuates nephrotoxicity in Monascus purpureus.

Journal: Journal of applied microbiology

Published: August 14, 2025

Efficacy and Safety of Biomaterials and Antimicrobial Dressings in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Network Meta-Analysis.

Efficacy and Safety of Biomaterials and Antimicrobial Dressings in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Network Meta-Analysis.

Journal: Journal of diabetes research

Published: June 03, 2025

Monascus fermentation enhances the lipid-lowering properties of ginseng in vivo and component assay.

Monascus fermentation enhances the lipid-lowering properties of ginseng in vivo and component assay.

Journal: Food research international (Ottawa, Ont.)

Published: May 23, 2025

Gut Microbiota-Targeted Intervention of Hyperlipidemia Using Monascus-Fermented Ginseng.

Gut Microbiota-Targeted Intervention of Hyperlipidemia Using Monascus-Fermented Ginseng.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 24, 2025

Unlocking Gut Health: Evaluation of Structure and Characteristics of Astragalus Polysaccharides Modified by Lactic Acid Bacteria Fermentation.

Unlocking Gut Health: Evaluation of Structure and Characteristics of Astragalus Polysaccharides Modified by Lactic Acid Bacteria Fermentation.

Journal: Probiotics and antimicrobial proteins

Published: December 13, 2024

Exploring the Prebiotic Potential of Fermented Astragalus Polysaccharides on Gut Microbiota Regulation In Vitro.

Exploring the Prebiotic Potential of Fermented Astragalus Polysaccharides on Gut Microbiota Regulation In Vitro.

Journal: Current microbiology

Published: August 12, 2024

Next-generation sequencing revealed factors associated with cumulative incidence of relapse and leukemia-free survival in patients with newly diagnosed acute myeloid leukemia.

Next-generation sequencing revealed factors associated with cumulative incidence of relapse and leukemia-free survival in patients with newly diagnosed acute myeloid leukemia.

Journal: Cancer pathogenesis and therapy

Published: July 10, 2022

High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling Donors.

High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling Donors.

Journal: Transplantation and cellular therapy

Published: June 15, 2022

Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies.

Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies.

Journal: Drug design, development and therapy

Published: December 16, 2021

Increased risk of nonrelapse mortality post T-cell-replete haploidentical stem cell transplantation in patients with recurrence of acute graft-versus-host disease.

Increased risk of nonrelapse mortality post T-cell-replete haploidentical stem cell transplantation in patients with recurrence of acute graft-versus-host disease.

Journal: Hematological oncology

Published: December 04, 2021

Ruxolitinib-corticosteroid as first-line therapy for newly diagnosed high-risk acute graft versus host disease: study protocol for a multicenter, randomized, phase II controlled trial.

Ruxolitinib-corticosteroid as first-line therapy for newly diagnosed high-risk acute graft versus host disease: study protocol for a multicenter, randomized, phase II controlled trial.

Journal: Trials

Published: June 14, 2021

Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy.

Elevated REG3α predicts refractory aGVHD in patients who received steroids-ruxolitinib as first-line therapy.

Journal: Annals of hematology

Published: March 26, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026